Your browser doesn't support javascript.
loading
Metformin diminishes the unfavourable impact of Nrf2 in breast cancer patients with type 2 diabetes.
Urpilainen, Elina; Kangaskokko, Jenni; Puistola, Ulla; Karihtala, Peeter.
Afiliação
  • Urpilainen E; 1 Department of Obstetrics and Gynaecology, PEDEGO Research Unit and Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
  • Kangaskokko J; 2 Department of Pathology and Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
  • Puistola U; 1 Department of Obstetrics and Gynaecology, PEDEGO Research Unit and Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
  • Karihtala P; 3 Department of Oncology and Radiotherapy and Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland.
Tumour Biol ; 41(1): 1010428318815413, 2019 Jan.
Article em En | MEDLINE | ID: mdl-30803422

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Diabetes Mellitus Tipo 2 / Fator 2 Relacionado a NF-E2 / Metformina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Diabetes Mellitus Tipo 2 / Fator 2 Relacionado a NF-E2 / Metformina Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article